Catecholaminergic polymorphic ventricular tachycardia laboratory findings: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Xyz}} {{CMG}}; {{AE}} ==Overview== An elevated/reduced concentration of serum/blood/urinary/CSF/other [lab test] is diagnostic of [disease name]. OR Laborator...")
 
No edit summary
 
(3 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Xyz}}
{{Catecholaminergic polymorphic ventricular tachycardia}}


{{CMG}}; {{AE}}  
{{CMG}}; {{AE}}{{MRV}}  


==Overview==
==Overview==
An elevated/reduced concentration of serum/blood/urinary/CSF/other [lab test] is diagnostic of [disease name].
There are no diagnostic laboratory findings associated with catecholaminergic polymorphic ventricular tachycardia.
 
OR
 
Laboratory findings consistent with the diagnosis of [disease name] include [abnormal test 1], [abnormal test 2], and [abnormal test 3].
 
OR
 
[Test] is usually normal for patients with [disease name].
 
OR
 
Some patients with [disease name] may have elevated/reduced concentration of [test], which is usually suggestive of [progression/complication].
 
OR
 
There are no diagnostic laboratory findings associated with [disease name].


==Laboratory Findings==
==Laboratory Findings==


There are no diagnostic laboratory findings associated with [disease name].
*There are no diagnostic laboratory findings associated with catecholaminergic polymorphic ventricular tachycardia.
 
*However, to exclude [[electrolyte]] abnormalities as the cause of [[ventricular tachycardia]], ionized [[calcium]], [[magnesium]] and [[phosphate]] levels should be obtained.<ref name="pmid3337132">{{cite journal |vauthors=Tchou P, Young P, Mahmud R, Denker S, Jazayeri M, Akhtar M |title=Useful clinical criteria for the diagnosis of ventricular tachycardia |journal=Am. J. Med. |volume=84 |issue=1 |pages=53–6 |date=January 1988 |pmid=3337132 |doi=10.1016/0002-9343(88)90008-3 |url=}}</ref><ref name="pmid4709549">{{cite journal |vauthors=Lown B, Temte JV, Arter WJ |title=Cardiac arrhythmias. 6. Ventricular tachyarrhythmias. Clinical aspects |journal=Circulation |volume=47 |issue=6 |pages=1364–81 |date=June 1973 |pmid=4709549 |doi=10.1161/01.cir.47.6.1364 |url=}}</ref>
OR
 
An elevated/reduced concentration of serum/blood/urinary/CSF/other [lab test] is diagnostic of [disease name].
 
OR
 
[Test] is usually normal among patients with [disease name].
 
OR
 
Laboratory findings consistent with the diagnosis of [disease name] include:
*[Abnormal test 1]
*[Abnormal test 2]
*[Abnormal test 3]
 
OR
 
Some patients with [disease name] may have elevated/reduced concentration of [test], which is usually suggestive of [progression/complication].


==References==
==References==

Latest revision as of 15:33, 23 July 2020

Catecholaminergic polymorphic ventricular tachycardia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Catecholaminergic polymorphic ventricular tachycardia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Exercise Stress Testing

Genetic Testing

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Implantable Cardioverter-Defibrillator

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Catecholaminergic polymorphic ventricular tachycardia laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Catecholaminergic polymorphic ventricular tachycardia laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Catecholaminergic polymorphic ventricular tachycardia laboratory findings

CDC on Catecholaminergic polymorphic ventricular tachycardia laboratory findings

Catecholaminergic polymorphic ventricular tachycardia laboratory findings in the news

Blogs on Catecholaminergic polymorphic ventricular tachycardia laboratory findings

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Catecholaminergic polymorphic ventricular tachycardia laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mounika Reddy Vadiyala, M.B.B.S.[2]

Overview

There are no diagnostic laboratory findings associated with catecholaminergic polymorphic ventricular tachycardia.

Laboratory Findings

References

  1. Tchou P, Young P, Mahmud R, Denker S, Jazayeri M, Akhtar M (January 1988). "Useful clinical criteria for the diagnosis of ventricular tachycardia". Am. J. Med. 84 (1): 53–6. doi:10.1016/0002-9343(88)90008-3. PMID 3337132.
  2. Lown B, Temte JV, Arter WJ (June 1973). "Cardiac arrhythmias. 6. Ventricular tachyarrhythmias. Clinical aspects". Circulation. 47 (6): 1364–81. doi:10.1161/01.cir.47.6.1364. PMID 4709549.

Template:WH Template:WS